The unhoused population in Saint John has topped 300 this year, and the community is bracing for the cold weather ahead. As ...
The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug. Biogen said Thursday that the drug, known in the U.S. as Leqembi, ...
The Office of the Seniors Advocate says it wants to learn more about how ageism is affecting people's daily lives, to better ...
The Saskatchewan legislature is to reconvene on Nov. 25, with the governing Saskatchewan Party's seat count severely reduced ...
Around 92% of people living in the UK have used at least one over-the-counter drug in the past year. While these drugs make ...
The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...
Prescriptions for a range of common 'over the counter' remedies are no longer available on the NHS after a crackdown in ...
The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...